Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1155 of 6351
-
Can a new drug called ZP9830 calm psoriasis Flare-Ups?
Symptom relief Recruiting nowThe purpose of this trial is to investigate the effects of repeated administration of ZP9830 for 8 weeks in participants with plaque psoriasis. Here, the primary aim is to evaluate safety and tolerability of ZP9830, the secondary aims are to test clinical efficacy and pharmacokin…
Phase 1 • Sponsor: Zealand Pharma • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Eccentric cycling: a gentler path to heart attack recovery?
Disease control Not yet recruitingThis clinical trial will evaluate a two-week eccentric exercise program conducted as part of comprehensive cardiac rehabilitation in patients after a heart attack (myocardial infarction). Eccentric exercise involves muscle contractions while the muscles are lengthening and may al…
Sponsor: Medical University of Gdansk • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
A common amino acid may shield kidneys after heart surgery — a massive analysis puts it to the test
Disease control Not yet recruitingAcute kidney injury (AKI) is common after cardiac surgery, yet effective protective strategies remain limited. L-arginine is the substrate for endogenous nitric oxide (NO) synthesis and may improve renal perfusion and endothelial function. investigators emulated a target trial to…
Sponsor: Xijing Hospital • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New insulin pump system aims to improve diabetes management
Disease control Recruiting nowThis study will demonstrate the safety and performance of the Novel Medtronic Experimental Automated Insulin Delivery system named MiniMed™ NMX8 system in people living with insulin-requiring diabetes in comparison with the MiniMed™ 780G system.
Sponsor: Medtronic MiniMed, Inc. • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
AI reads CT scans to spot liver cancer before It's too late
Diagnosis Recruiting nowThis study aims to assess the feasibility of leveraging non-contrast CT and artificial intelligence to detect liver cancer in consecutive real-world patients. To this end, we deploy LEAF in a prospective real-world clinical setting for real-time monitoring, with a particular focu…
Sponsor: Zhejiang University • Aim: Diagnosis
Last updated Jul 19, 2026 00:00 UTC
-
Could a single dose of infliximab speed kidney recovery in immunotherapy patients?
Disease control Not yet recruitingThis is a multi-center, 1:1 randomized pilot study examining the efficacy and safety of infliximab 5mg/kg x 1 paired with 2 weeks of prednisone 1mg/kg per day for 2 weeks versus standard-of-care glucocorticoid therapy (prednisone 1mg/kg/day x 2 weeks followed by a 4 week taper) o…
Phase 4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Dropping aspirin after a heart attack: a safer path or a risky gamble?
Disease control Not yet recruitingThis randomized controlled trial aims to evaluate the safety and efficacy of an aspirin-free strategy after 3-6 months of dual antiplatelet therapy (DAPT) in patients with acute coronary syndrome (ACS) who have undergone complete coronary revascularization by percutaneous coronar…
Phase 4 • Sponsor: Assiut University • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Tiny activity 'Snacks' may sharpen minds in COPD
Disease control Not yet recruitingThis clinical trial aims to evaluate whether a culturally adapted Snacktivity™ program can improve cognitive function and self-care abilities in patients with Chronic Obstructive Pulmonary Disease (COPD) in Hong Kong. The main questions it aims to answer are: 1. Does the Snackt…
Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could an arthritis drug shield heart and kidneys in metabolic syndrome?
Disease control Not yet recruitingThis is a prospective, randomized, open-label, parallel-controlled clinical trial to evaluate the efficacy and safety of targeted IL-17A inhibition with secukinumab on cardiovascular and renal endpoints in 100 patients with cardiorenal metabolic syndrome and atherosclerotic cardi…
Phase 4 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Bionic balloon could shorten labor and cut C-Section rates
Disease control Not yet recruitingThis multicenter, prospective, randomized controlled trial will evaluate the efficacy and safety of bionic balloon-assisted delivery technology in nulliparous women planning vaginal delivery. Eligible participants will be randomly assigned in a 1:1 ratio to either the interventio…
Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New Two-Step therapy aims to stop chronic kidney transplant rejection
Disease control Not yet recruitingThis multicenter, prospective, single-arm exploratory study evaluates the efficacy and safety of a novel sequential regimen for chronic active antibody-mediated rejection (caABMR) in kidney transplant recipients: single-dose CD38 monoclonal antibody (1800 mg subcutaneous) inducti…
Sponsor: wujianyong • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Brain scans reveal how a Weight-Loss drug may rewire food cravings
Knowledge-focused Recruiting nowThe goal of this clinical trial is to investigate how semaglutide affects the way the brain responds to food in adults with obesity and food addiction tendencies. The main goals of this study are: * To see if semaglutide changes dopamine-related activity in the brain during the…
Sponsor: Seoul National University Hospital • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
App sends mindfulness exercises right after weight regain to keep dieters on track
Disease control Recruiting nowThis trial will test the effectiveness of a weight loss maintenance intervention designed to help participants respond more adaptively to weight regain. Participants will be randomly assigned to one of two conditions. In one condition, participants will receive brief exercises (e…
Sponsor: ORI Community and Evaluation Services • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New drug aims to cut blood removal in rare cancer
Disease control Recruiting nowPolycythemia vera (PV) is a rare blood cancer in which the body makes too many red blood cells. This can make the blood thicker and may increase the risk of serious health problems such as blood clots. Many people with PV need regular phlebotomy, which is a procedure to remove bl…
Phase 2 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New HIV combo pill tested for rapid start in 100 patients
Disease control Not yet recruitingProtocol title: "Efficacy and safety of doravirine in the rapid initiation of highly active antiretroviral therapy (HAART) in HIV-1positive patients without prior treatment."
Phase 4 • Sponsor: Fundación Huésped • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Smart blood culture bottle aims to identify sepsis-causing bacteria in hours, not days
Knowledge-focused Recruiting nowIn the context of a bacteremia, although significant progress has been made in speeding up pathogen identification once a blood culture bottle turns positive, few cost-effective solutions have been proposed to improve the earlier stages of the process-specifically, from blood col…
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Fatty liver may be a hidden driver of heart attacks in diabetes
Knowledge-focused Not yet recruitingThis study aims to address the following key scientific question by establishing a large-scale, high-standard clinical cohort: the independent contribution of MASLD and its progression to liver fibrosis on cardiovascular outcomes in patients with T2DM, after excluding the confoun…
Sponsor: The Affiliated Hospital of Hangzhou Normal University • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Stem cell donation: one shot or two? trial seeks best way to mobilize cells
Disease control Recruiting nowNational and international guidelines/consensus recommend G-CSF (granulocyte colony-stimulating factor) at 10 μg/kg/day as a single daily dose or divided into two daily doses for mobilization in healthy donors for allogeneic hematopoietic stem cell transplantation. However, there…
Phase 3 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Can a Cholesterol-Lowering injection help lung cancer patients stay on a key treatment?
Disease control Not yet recruitingThis prospective single-arm clinical study plans to enroll 29 participants with unresectable stage IIIB-IV ALK fusion-positive non-small cell lung cancer (NSCLC). Eligible patients must be aged ≥18 years with an ECOG performance status of 0-2 and have developed grade 1-3 hypercho…
Phase 4 • Sponsor: Hunan Cancer Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a daily electric zap to the eye preserve sight in dry AMD?
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the efficacy and safety of an electric stimulator for medical use by personal (LRTPM1) in patients with early to intermediate dry age-related macular degeneration. The main questions this study aims to answer are: * Does the invest…
Sponsor: Nu Eyne Co., Ltd. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC